DIVA Laboratories, Ltd. (TPEX:4153)
30.55
+0.15 (0.49%)
Apr 29, 2026, 1:30 PM CST
DIVA Laboratories Revenue
In the year 2025, DIVA Laboratories had annual revenue of 868.84M TWD with 0.76% growth. DIVA Laboratories had revenue of 229.72M in the quarter ending December 31, 2025, with 2.89% growth.
Revenue
868.84M
Revenue Growth
+0.76%
P/S Ratio
2.02
Revenue / Employee
5.74M
Employees
154
Market Cap
1.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.84M | 6.52M | 0.76% |
| Dec 31, 2024 | 862.32M | -31.52M | -3.53% |
| Dec 31, 2023 | 893.84M | -55.36M | -5.83% |
| Dec 31, 2022 | 949.20M | 236.97M | 33.27% |
| Dec 31, 2021 | 712.23M | -24.69M | -3.35% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genetics Generation Advancement | 603.11M |
| BIONET | 1.24B |
| Kim Forest Enterprise | 549.14M |
| Sofiva Genomics | 385.71M |
| Puriblood Medical | 117.35M |
| Pharmigene | 149.25M |
| Welgene Biotech | 375.94M |